Fig. 4From: Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4Typical chromatogram of the purified and formulated [11C]erlotinib using the optimized analytical HPLC (top: UV-channel; bottom: radioactivity-channel)Back to article page